All In MedTech

FDA Clearance Tracker · P100026-S034

NEUROPACE RNS SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 30, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 30, 2015

Approved

Time to decision

55 days

Received May 6, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100026-S034
Device name
NEUROPACE RNS SYSTEM
Applicant location
Mountain View, CA
Received
May 6, 2015
Decided
Jun 30, 2015
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P100026

Device type

Device class
Class III

Every decision under product code PFN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for NeuroPace, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.